Expert Perspectives on Practice-Changing Strategies for Improved Patient Outcomes in Multiple Myeloma - Part 1

STATEMENT OF NEED Multiple myeloma is a B-cell neoplasm that occurs primarily in older adults. The incidence is expected to rise in conjunction with the aging population. Because symptoms often do not appear until the malignancy is in advanced stages, early diagnosis is difficult, and the 5-year relative survival rate remains only 54% (ACS, 2021). Following diagnosis, management must be guided by cytogenic markers with prognostic significance and correct staging based upon these markers (NC...
i3 Health

Therapy of B-Cell Acute Lymphoblastic Leukemia: An Evolving Landscape

Presented by Amir Fathi, MD, Associate Professor of Medicine at Harvard Medical School, this activity will highlight individualized treatment selection for patients with acute lymphoblastic leukemia (ALL), as well as recent efficacy and safety data for novel therapeutic strategies. Start the activity now. STATEMENT OF NEED Acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the proliferation of immature lymphoid cells throughout the bone marrow and blood (Rana...
i3 Health

Improving Outcomes in Hodgkin Lymphoma

This in-depth discussion, presented by Louis Diehl, MD, Professor of Medicine at Duke University Medical School, will feature strategies for incorporating predictive and prognostic markers, recent efficacy and safety data, and adverse event management strategies into treatment selection for patients with Hodgkin lymphoma (HL). Start the activity now. STATEMENT OF NEED Hodgkin lymphoma (HL) is a rare malignancy of the lymph nodes and lymphatic system, with about 8,830 new cases diagnosed ...
i3 Health

Updates in Myelodysplastic Syndromes: Improving Patient Outcomes

This activity, presented by Mikkael Sekeres, MD, Chief of the Division of Hematology at the University of Miami Health System, will focus on predictive and prognostic markers for myelodysplastic syndromes (MDS), emerging data on novel therapies, and strategies to optimize safety and tolerability for patients with this disease. Start the activity now. STATEMENT OF NEED Myelodysplastic syndromes (MDS) comprise a heterogeneous group ofmyeloid malignanciesthat derive from abnormal multipot...
i3 Health

Keeping Up with Advances in MS: Cases in Diagnosis and Treatment, A Case-Based Roadmap for Improved Patient Outcomes in Multiple Sclerosis

Join Edward Fox, MD, PhD, and Matthew Schindler, MD, PhD, in an interactive case-based roadmap for improved outcomes in patients with MS. In addition to addressing diagnostic challenges, Drs. Fox and Schindler share their insights into integrating advances in the pharmacologic treatment of patients with MS, focusing on the safety and efficacy of targeted therapies.
Annenberg Center for Health Sciences at Eisenhower

Advances In™ PAH Associated with Congenital Heart Disease (PAH-CHD): Designing New Treatment Strategies Backed by Better Disease Understanding

Target Audience This online educational activity is directed toward cardiologists, pulmonologists, NPs, PAs, and RNs. Additional healthcare professionals involved in the management and treatment of patients with PAH-CHD will also be invited to participate in this activity. Program Overview Pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is a lethal and progressive disease in which prostacyclin, nitric oxide, and endothelin-1 pathways are disturbed and co...
Physicians’ Education Resource®, LLC

Through the Patient/Family Looking Glass: Perspectives in Treatment Planning by Disease Compartments for Pediatric Neuroblastoma

Target Audience The educational design of this activity addresses the needs of pediatric oncology nurses, advanced practice providers (including nurse practitioners and physician assistants), pediatric oncologists, social workers, and other members of the team caring for children with pediatric neuroblastoma. Statement of Need/Program Overview With an ever-improving understanding of clinical and biological risk factors, treatment strategies for pediatric neuroblastoma have become more...
Global Education Group and PlatformQ Health Education, LLC, in conjunction with the 2021 SIOP Virtual Conference.

Evaluating the Value of Whole Genomic Sequencing in Critically ill Neonates

Originally presented at the Hot Topics in Neonatology Nemours 2021 Annual Meeting, this presentation is now available as an on-demand webinar. Join us as we discuss whole genome sequencing as a first-tier test in the NICU/PICU setting. The faculty will assess the use of WES/ WGS in acutely ill neonates as a diagnostic and prognostic tool providing rapid results that facilitate timelier medical management.
EXCEL Continuing Education

Updates in Mantle Cell Lymphoma

Discover insights on predictive and prognostic markers, emerging efficacy and safety data, strategies to optimize tolerability for patients receiving novel therapies for mantle cell lymphoma (MCL), and more in this case-based activity presented by John Leonard, MD, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology at Weill Cornell Medicine. Start the activity now. STATEMENT OF NEED Mantle cell lymphoma (MCL) is an aggressive variant of B-cell non-Hodgkin ly...
i3 Health

Treatment Advances in Waldenstrom Macroglobulinemia

In this case-based discussion, Morie Gertz, MD, Chair of General Internal Medicine at the Mayo Clinic in Minnesota, will discuss how to use predictive and prognostic markers to select treatment for patients with Waldenstrom macroglobulinemia (WM) and how to appraise emerging clinical trial data and adverse event management strategies for novel treatments. Start the activity now. STATEMENT OF NEED Waldenstrom macroglobulinemia (WM) is a rare cancer of B lymphocytes associated with lymphop...
i3 Health

Reading Disorders: Visual-Perceptual-Spatial Disabilities - Judith Likavek Davis, MA, SLP

Reading disorders are complex and are comprised of difficulties across multiple domains. This course presents a categorical framework for the description and treatment of reading disabilities. Visual-perceptual-spatial reading disorders will be emphasized. Description, differential diagnosis, prognostic indicators, evaluation procedures, case studies and hands-on treatment strategies will be provided. This seminar represents part one of a four-part series.
Speech Therapy Professional Development

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map